Conference home page

Conference Overview:

Sponsorship:

Speaking:

Sponsored By:

Supported By:

Pharmaceutical Industry

Directors and Managers of Regulatory/Government Affairs, Business Development, Market Access; Product Managers; Marketing and Sales

• Understand New Regulations: Ensure you keep your pipeline flowing with a complete understanding of the evolving regulatory atmosphere.
• Optimize Reimbursement: Develop an integrated reimbursement strategy to make the most of the benefits of your biologic.
• Capitalize On New Opportunities: Take advantage of the wealth of opportunities for new products and revenue streams.

Biotechnology Industry

Directors and Managers of Regulatory/Government Affairs, Business Development; Medical Directors

• Form Mutually Beneficial Partnerships: Secure alliances to ensure that your R&D dollars realize optimal ROI.
• Drive New Strategies: Open up a wider stage to have the potential of your biologics realized and benefit from new opportunities.
• Innovate: Lead the way with fresh approaches to enhance health care with accessible therapies and vaccines.

Federal and Provincial Government; Regulatory Bodies; Professional Associations

• Cost-Effective Health Outcomes: Ensure that Canadians have access to the most effective treatments in the most cost-effective way.
• Foster Innovation: Take steps to keep Canada competitive on the global biopharmaceutical stage.

Market Access and Reimbursement Strategies Consultants

• Form New Alliances: Generate new contacts and collaborate with industry leaders.
• Learn New Developments: Recognize advantages and challenges of the next generation of biologics.

Specialty Medical Device and Packaging Suppliers; Shipping and Storage Specialists

• Network With Key Decision-Makers: Identify new opportunities and trends developing from the ongoing changes.
• Be Where The Action Is: Hear insightful presentations from the most successful initiatives across Canada.

Hear What Delegates Said About Last Year’s Event:

“Useful – good to listen to the thoughts of pharmaceutical leaders from different perspectives!”
Vaneeta Bhatia, Regulatory Affairs Specialist, CSL Behring Canada, Inc.

“Good learning opportunities for Biologics challenges.”
Neeraj Pandey, Manager of Regulatory Affairs, Sanofi-Pasteur

“Excellent information for realizing the tough market for Biologics.”
Marie-Helene Cote, Drug Regulatory Affairs Associate, Novartis Pharma Canada